Astrocyte Senescence as a Component of Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Aging is the main risk factor for Alzheimer's disease (AD); however, the aspects of the aging process that predispose the brain to the development of AD are largely unknown. Astrocytes perform a myriad of functions in the central nervous system to maintain homeostasis and support neuronal function. In vitro, human astrocytes are highly sensitive to oxidative stress and trigger a senescence program when faced with multiple types of stress. In order to determine whether senescent astrocytes appear in vivo, brain tissue from aged individuals and patients with AD was examined for the presence of senescent astrocytes using p16(INK4a) and matrix metalloproteinase-1 (MMP-1) expression as markers of senescence. Compared with fetal tissue samples (n = 4), a significant increase in p16(INK4a)-positive astrocytes was observed in subjects aged 35 to 50 years (n = 6; P = 0.02) and 78 to 90 years (n = 11; P<10(-6)). In addition, the frontal cortex of AD patients (n = 15) harbored a significantly greater burden of p16(INK4a)-positive astrocytes compared with non-AD adult control subjects of similar ages (n = 25; P = 0.02) and fetal controls (n = 4; P<10(-7)). Consistent with the senescent nature of the p16(INK4a)-positive astrocytes, increased metalloproteinase MMP-1 correlated with p16(INK4a). In vitro, beta-amyloid 1-42 (Aβ(1-42)) triggered senescence, driving the expression of p16(INK4a) and senescence-associated beta-galactosidase. In addition, we found that senescent astrocytes produce a number of inflammatory cytokines including interleukin-6 (IL-6), which seems to be regulated by p38MAPK. We propose that an accumulation of p16(INK4a)-positive senescent astrocytes may link increased age and increased risk for sporadic AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In many prevalent neurodegenerative conditions including Alzheimer's Disease, brain tissue biopsies are present with increased levels of p16INK4a- positive astrocytes, MMP-1 and IL-6”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Astrocytes cultured from patients with AD express not only more of the CDKi p16 INK4A than age-matched controls, but also more MMP1 and IL-6 (57).”
From Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018) · cites this paper as [57]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have highlighted senescence in multiple brain cell types in AD [3, 16, 32, 52, 80].”
From Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics (2024) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In the context of aging and neurodegenerative disease, senescent cell accumulation has been identified in multiple cell types within the central nervous system (CNS), including neurons6,7,14,15, astrocytes16,17, microglia8,18, oligodendrocyte precursor cells19 and endothelial cells20.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, prior research conducted on postmortem brain tissue from individuals with AD has identified senescent astrocytes16, and mouse models have demonstrated that they are cleared with senolytic treatment8,17.”
From Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial (2023) · cites this paper as [16]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“Staining for Senescence-associated b-galactosidase Senescence-associated beta-galactosidase (SA b-gal) staining was performed as previously described [62].”
MethodThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 11×
“One component of the SASP present in multiple cell types is IL-6.”
BackgroundInfluentialAstrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196 · cited 1×
“Astrocytes regulate the contents of the synaptic cleft and synaptic transmission as part of the tripartite synapse, control CNS metabolism, and maintain blood brain barrier integrity [10,11].”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291 · cited 1×
“The increased dosage of synthetic versus cell-derived Ab oligomers required to trigger senescence, correlates with reports on the effects of Ab on rat hippocampal long-term potentiation [53].”
BackgroundShankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“demonstrated by the phenotypic improvement observed following the targeted removal of senescent cells in a progeroid mouse model [9].”
BackgroundInfluentialMechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580 · cited 1×
“In vitro, we found that exposure of astrocytes to Ab1–42 triggers senescence and that senescent astrocytes produce high quantities of interleukin-6 (IL-6), a cytokine known to be increased in the CNS of AD patients [18].”
Background2013 Alzheimer's disease facts and figures
Alzheimer's Association, Thies, W., & Bleiler, L. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,328
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 1×
“We selected the age ranges of 35–50 years and 78–90 years (Figure 3B) in order to compare a group that is least likely to have AD and a group that is most likely to have AD [31].”
MethodBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687 · cited 1×
“The Ab produced by these cells is biologically relevant as judged by a significant disruption in working memory when delivered to rats [22,60].”
BackgroundShankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486 · cited 1×
“p16 has emerged as a robust in vivo biomarker of senescence in human and rodent tissues [27,28].”
BackgroundInflammatory networks during cellular senescence: causes and consequences.
Freund, A., Orjalo, A. V., Desprez, P.-Y., & Campisi, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.003 · Cited by 1,354 · cited 1×
“Several inflammatory markers found to be robustly changed in other cell types were not as dramatically altered in senescent (replicative) astrocytes according to our array [25].”
BackgroundCellular Senescence in Aging Primates
Herbig, U., Ferreira, M., Condel, L., Carey, D., & Sedivy, J. M. (2006) · Science · doi:10.1126/science.1122446 · Cited by 1,101
Freund, A., Patil, C. K., & Campisi, J. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.69 · Cited by 1,039 · cited 1×
“Therefore, we examined senescent astrocytes for activation of p38 mitogen-activated protein kinase (p38MAPK), which is a mediator of the senescence arrest in response to diverse stimuli [39] and a known regulator of the SASP in other cell types [40].”
BackgroundIn vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis
Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015 · cited 1×
“Preparation of Oligomeric Beta-amyloid Synthetic Ab1–42 (American Peptide; Sunnyvale, CA) was oligomerized as described [56,57].”
MethodGENETICS OF SOMATIC MAMMALIAN CELLS
Puck, T. T., Cieciura, S. J., & Robinson, A. (1958) · The Journal of Experimental Medicine · doi:10.1084/jem.108.6.945 · Cited by 960 · cited 1×
“CHO cells, originally derived from Chinese hamster ovary [61], were available and carried in our laboratory.”
Method2011 Alzheimer's disease facts and figures
Alzheimer's Association (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.02.004 · Cited by 908
Evidence that production and release of amyloid beta-protein involves the endocytic pathway
Koo, E. H., & Squazzo, S. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32449-3 · Cited by 829
Inflammatory processes in Alzheimer's disease
Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782
Interleukin-6 in Aging and Chronic Disease: A Magnificent Pathway
Maggio, M., Guralnik, J. M., Longo, D. L., & Ferrucci, L. (2006) · The Journals of Gerontology: Series A · doi:10.1093/gerona/61.6.575 · Cited by 692
Senescent cells as a source of inflammatory factors for tumor progression
Davalos, A. R., Coppe, J.-P., Campisi, J., & Desprez, P.-Y. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9220-9 · Cited by 636 · cited 1×
“In addition to its association with fibroblast senescence [8,23], IL-6 is thought to be a major mediator of chronic inflammation associated with aging and aging-related diseases including AD [24–26].”
BackgroundAbramov, A. Y., Canevari, L., & Duchen, M. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4042-03.2004 · Cited by 587
Accumulation of senescent cells in Mitotic tissue of aging primates
Jeyapalan, J. C., Ferreira, M., Sedivy, J. M., & Herbig, U. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.008 · Cited by 571 · cited 1×
“age in several tissues [5], little is known about the potential”
Backgroundp16 INK4A is a robust in vivo biomarker of cellular aging in human skin
Ressler, S., Bartkova, J., Niederegger, H., Bartek, J., Scharffetter‐Kochanek, K., Jansen‐Dürr, P., & Wlaschek, M. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00231.x · Cited by 557 · cited 2×
“p16 has emerged as a robust in vivo biomarker of senescence in human and rodent tissues [27,28].”
BackgroundResultAlveolar Cell Senescence in Patients with Pulmonary Emphysema
Tsuji, T., Aoshiba, K., & Nagai, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1374oc · Cited by 527 · cited 1×
“This is consistent with reports indicating similar in vivo increases in p16 in human aged skin [27], kidney [32], lung [33], and heart [34].”
ResultCoppé, J.-P., Rodier, F., Patil, C. K., Freund, A., Desprez, P.-Y., & Campisi, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257071 · Cited by 506
Cellular senescence: a link between cancer and age-related degenerative disease?
Campisi, J., Andersen, J. K., Kapahi, P., & Melov, S. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.001 · Cited by 421 · cited 2×
“They secrete cytokines and proteases that profoundly affect neighboring cells, and may contribute to age-related declines in organ function [7].”
BackgroundThe Oligomerization of Amyloid β-Protein Begins Intracellularly in Cells Derived from Human Brain
Walsh, D. M., Tseng, B. P., Rydel, R. E., Podlisny, M. B., & Selkoe, D. J. (2000) · Biochemistry · doi:10.1021/bi001048s · Cited by 401 · cited 1×
“Koo; University of California, San Diego) stably expresses the mutant amyloid precursor protein (APP) gene as previously described [58], and secretes Ab peptides at levels similar to those found in human brains affected by AD and normal cerebrospinal fluid (,1–2 nM) [59].”
BackgroundMitogen‐activated protein kinase p38 defines the common senescence‐signalling pathway
Iwasa, H., Han, J., & Ishikawa, F. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00620.x · Cited by 391 · cited 1×
“Therefore, we examined senescent astrocytes for activation of p38 mitogen-activated protein kinase (p38MAPK), which is a mediator of the senescence arrest in response to diverse stimuli [39] and a known regulator of the SASP in other cell types [40].”
BackgroundChimenti, C., Kajstura, J., Torella, D., Urbanek, K., Heleniak, H., Colussi, C., Di Meglio, F., Nadal-Ginard, B., Frustaci, A., Leri, A., et al. (2003) · Circulation Research · doi:10.1161/01.res.0000093985.76901.af · Cited by 386 · cited 1×
“This is consistent with reports indicating similar in vivo increases in p16 in human aged skin [27], kidney [32], lung [33], and heart [34].”
ResultTargeting p38 MAPK pathway for the treatment of Alzheimer's disease
Munoz, L., & Ammit, A. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.11.010 · Cited by 369 · cited 1×
“the cognitive decline associated with AD pathophysiology [41,42].”
BackgroundReactive Astrocytes As Therapeutic Targets for CNS Disorders
Hamby, M. E., & Sofroniew, M. V. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.003 · Cited by 365 · cited 1×
“A common pathological feature of many neurodegenerative disease states, including AD, is reactive astrogliosis, which is a wellcharacterized spectrum of changes that occurs in astrocytes in response to a variety of insults [55].”
BackgroundCellular senescence and organismal aging
Jeyapalan, J. C., & Sedivy, J. M. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.04.001 · Cited by 346
Salminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., & Soininen, H. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07738.x · Cited by 333 · cited 3×
“The importance of senescent astrocytes in age-related dementia has been the subject of recent discussion [14], but to date, there is little evidence to suggest that senescent astrocytes accumulate in the brain.”
BackgroundInfluentialCoppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · cited 1×
“Evidence coming mainly from fibroblast models indicates that senescent cells secrete pro-inflammatory mediators and proteases that not only potentiate clearance of senescent cells through immune surveillance, but may also contribute to age-related declines in organ function [7,8,45].”
BackgroundBachstetter, A. D., Xing, B., de Almeida, L., Dimayuga, E. R., Watterson, D. M., & Van Eldik, L. J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-79 · Cited by 282
Allaman, I., Gavillet, M., Bélanger, M., Laroche, T., Viertl, D., Lashuel, H. A., & Magistretti, P. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5098-09.2010 · Cited by 278
Hu, J., Akama, K. T., Krafft, G. A., Chromy, B. A., & Van Eldik, L. J. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01318-8 · Cited by 262
Neurological Diseases as Primary Gliopathies: A Reassessment of Neurocentrism
Verkhratsky, A., Sofroniew, M. V., Messing, A., deLanerolle, N. C., Rempe, D., Rodríguez, J. J., & Nedergaard, M. (2012) · ASN Neuro · doi:10.1042/an20120010 · Cited by 248 · cited 1×
“The chronic, subtle loss of astrocyte ability to maintain homeostasis throughout the CNS is now thought to underlie AD pathogenesis [54].”
BackgroundWest, M. D., Pereira-Smith, O. M., & Smith, J. R. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90372-8 · Cited by 241 · cited 2×
“expression of MMP-1 has been reported in normal senescent human and Werner fibroblasts [37,46,47].”
BackgroundTripartite synapses: Roles for astrocytic purines in the control of synaptic physiology and behavior
Halassa, M. M., Fellin, T., & Haydon, P. G. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.031 · Cited by 230
Stress-induced senescence in human and rodent astrocytes
Bitto, A., Sell, C., Crowe, E., Lorenzini, A., Malaguti, M., Hrelia, S., & Torres, C. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.06.021 · Cited by 204
Self-citationRhein, V., Baysang, G., Rao, S., Meier, F., Bonert, A., Müller-Spahn, F., & Eckert, A. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9398-y · Cited by 198
Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes
Myung, N.-H., Zhu, X., Kruman, I. I., Castellani, R. J., Petersen, R. B., Siedlak, S. L., Perry, G., Smith, M. A., & Lee, H.-G. (2008) · AGE · doi:10.1007/s11357-008-9050-7 · Cited by 170
Astrocytes aged in vitro show a decreased neuroprotective capacity
Pertusa, M., García‐Matas, S., Rodríguez‐Farré, E., Sanfeliu, C., & Cristòfol, R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04369.x · Cited by 168 · cited 1×
“with age in vivo that parallels functional declines in vitro [12].”
BackgroundChkhotua, A. B., Gabusi, E., Altimari, A., D’Errico, A., Yakubovich, M., Vienken, J., Stefoni, S., Chieco, P., Yussim, A., & Grigioni, W. F. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00363-9 · Cited by 120 · cited 1×
“This is consistent with reports indicating similar in vivo increases in p16 in human aged skin [27], kidney [32], lung [33], and heart [34].”
ResultLivney, M. G., Clark, C. M., Karlawish, J. H., Cartmell, S., Negrón, M., Nuñez, J., Xie, S. X., Entenza-Cabrera, F., Vega, I. E., & Arnold, S. E. (2011) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181f7d881 · Cited by 98 · cited 1×
“Although the average age at initial presentation of AD ranges from 68–73 years across different ethnicities, neuropathologic changes characteristic of AD can precede clinical symptoms by up to twenty years [29,30].”
BackgroundGolde, T. E., & Miller, V. M. (2009) · Alzheimer's Research & Therapy · doi:10.1186/alzrt5 · Cited by 98 · cited 1×
“Senescence in other cell types of the CNS, including neurons, has been postulated as important risk factor for AD [48].”
BackgroundPoling, A. D., Morgan-Paisley, K., Panos, J., Kim, E., O‘Hare, E., Cleary, J. P., Lesné, S., Ashe, K. H., Porritt, M., & Baker, L. E. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.06.001 · Cited by 86 · cited 1×
“The Ab produced by these cells is biologically relevant as judged by a significant disruption in working memory when delivered to rats [22,60].”
BackgroundCerebellar diffuse amyloid plaques are derived from dendritic Aβ42 accumulations in Purkinje cells
Wang, H.-Y., D’Andrea, M. R., & Nagele, R. G. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00279-2 · Cited by 86 · cited 1×
“This finding is consistent with a diffuse cerebellar amyloid plaque formation and relative lack of cerebellar pathology in AD [35,36].”
ResultAβ oligomers inhibit synapse remodelling necessary for memory consolidation
Freir, D. B., Fedriani, R., Scully, D., Smith, I. M., Selkoe, D. J., Walsh, D. M., & Regan, C. M. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.01.001 · Cited by 85
Ahronheim, J. C. (1983) · JAMA · doi:10.1001/jama.250.9.1182 · Cited by 85
Donnini, S., Solito, R., Cetti, E., Corti, F., Giachetti, A., Carra, S., Beltrame, M., Cotelli, F., & Ziche, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-146456 · Cited by 80 · cited 1×
“Similarly, Ab peptides accelerate the senescence of endothelial cells in vitro and in vivo in the zebrafish model [49].”
BackgroundAmyloid plaques in cerebellar cortex and the integrity of Purkinje cell dendrites
Li, Y.-T., Woodruff‐Pak, D. S., & Trojanowski, J. Q. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90139-2 · Cited by 78 · cited 1×
“This finding is consistent with a diffuse cerebellar amyloid plaque formation and relative lack of cerebellar pathology in AD [35,36].”
ResultSelf-citationFa, M., Orozco, I. J., Francis, Y. I., Saeed, F., Gong, Y., & Arancio, O. (2010) · Journal of Visualized Experiments · doi:10.3791/1884 · Cited by 73 · cited 1×
“Preparation of Oligomeric Beta-amyloid Synthetic Ab1–42 (American Peptide; Sunnyvale, CA) was oligomerized as described [56,57].”
MethodTresini, M., Mawal-Dewan, M., Cristofalo, V. J., & Sell, C. (1998) · PubMed · Cited by 69
Self-citationThe effects of amyloid-β42 oligomer on the proliferation and activation of astrocytes in vitro
Hou, L., Liu, Y., Wang, X., Ma, H., He, J., Zhang, Y., Yu, C.-H., Guan, W., & Ma, Y.-H. (2011) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-011-9439-y · Cited by 57 · cited 1×
“The level of soluble Ab oligomers in AD brain correlates better with disease severity as compared with the level insoluble fibrillar Ab [50]; therefore, we chose to use Ab oligomers at concentrations previously shown to affect astrocytes [51,52].”
BackgroundZeng, G., & Millis, A. J. T. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0019 · Cited by 51 · cited 1×
“expression of MMP-1 has been reported in normal senescent human and Werner fibroblasts [37,46,47].”
BackgroundCellular Senescence in Aging Primates
THIERS, B. H. (2007) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70516-1 · Cited by 46
(1999) · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m · cited 1×
“The level of soluble Ab oligomers in AD brain correlates better with disease severity as compared with the level insoluble fibrillar Ab [50]; therefore, we chose to use Ab oligomers at concentrations previously shown to affect astrocytes [51,52].”
Background
Cited by
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
A proteomic atlas of senescence-associated secretomes for aging biomarker development
Basisty, N., Kale, A., Jeon, O. H., Kuehnemann, C., Payne, T., Rao, C., Holtz, A., Shah, S., Sharma, V., Ferrucci, L., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000599 · Cited by 1,348
“In addition to aging, MMP1 has been identified as a biomarker for several cancers, pulmonary fibrosis, and potentially Alzheimer’s disease (Bhat et al., 2012; Chen et al., 2016; Rosas et al., 2008; Roy et al., 2009), whereas STC1 has been identified as a diagnostic and prognostic biomarker for cancers, pulmonary fibro…”
BackgroundClearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Bussian, T. J., Aziz, A., Meyer, C. F., Swenson, B. L., van Deursen, J. M., & Baker, D. J. (2018) · Nature · doi:10.1038/s41586-018-0543-y · Cited by 1,289
Senescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Metadata
- Authors
- Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C.
- Affiliations
- Drexel University (US)
- University of Pennsylvania (US)
- Corresponding author
- Torres, Claudio
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-09-12
- Volume
- 7
- Issue
- 9
- Pages
- e45069
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3440417
- OpenAlex
- W2026433865
- Cited by
- 586
- References
- 64
- Citations by year
- 2026: 44 · 2025: 56 · 2024: 68 · 2023: 54 · 2022: 52 · 2021: 59 · 2020: 53 · 2019: 47 · 2018: 37 · 2017: 27 · 2016: 31 · 2015: 17 · 2014: 30 · 2013: 7 · 2012: 3
- FWCI
- 12.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Drexel University
- National Institutes of Health
- University of California, San Diego
- College of Medicine, Drexel University
- National Institute on Aging (AG022443-S1, AG022443, R01AG022443)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- astrocyte senescence, Alzheimer's disease, aging, p16INK4a, MMP-1, amyloid-beta 42, oxidative stress, senescence-associated β-galactosidase, interleukin-6, p38 MAPK, neuroinflammation, frontal cortex, sporadic Alzheimer's disease
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Astrocytes, Brain, Cells, Cultured, Cricetulus, Female, Cricetinae, Humans, Male, Microscopy, Fluorescence, Middle Aged, Peptide Fragments, Immunoblotting, Biomarkers, Interleukin-6, Amyloid beta-Peptides, CHO Cells, Cellular Senescence, Cyclin-Dependent Kinase Inhibitor p16, Matrix Metalloproteinase 1, p38 Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.